Literature DB >> 2507087

Molecular basis of insulin receptor function.

M D Houslay, K Siddle.   

Abstract

Insulin regulates a wide spectrum of metabolic processes in a variety of tissues. In addition, insulin is a potent growth factor, promoting normal cell growth and division in cultured cells, though the physiological importance of such actions in man is less certain. Some of the effects of insulin are very rapid and apparent within seconds, for example those on transport processes and the activity of regulatory enzymes. Other effects, such as those on enzyme concentrations and cell growth, may be manifest only over a period of many minutes or even hours. Such differences in time dependence may be more a reflection of the nature of the processes themselves than an indication of different signalling mechanisms. However, it is still unclear whether the regulation of diverse metabolic processes by insulin involves just one or multiple distinct primary intracellular signals. We will review here what is at present known about the structure and activity of the receptor, and current ideas on signalling mechanisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507087     DOI: 10.1093/oxfordjournals.bmb.a072316

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  7 in total

1.  Identification of glutamate-169 as the third zinc-binding residue in proteinase III, a member of the family of insulin-degrading enzymes.

Authors:  A B Becker; R A Roth
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

2.  Insulin stimulates the tyrosyl phosphorylation and activation of the 52 kDa peripheral plasma-membrane cyclic AMP phosphodiesterase in intact hepatocytes.

Authors:  N J Pyne; W Cushley; H G Nimmo; M D Houslay
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

3.  Diabetes abolishes the GTP-dependent, but not the receptor-dependent inhibitory function of the inhibitory guanine-nucleotide-binding regulatory protein (Gi) on adipocyte adenylate cyclase activity.

Authors:  D Strassheim; G Milligan; M D Houslay
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

4.  Phosphorylation of calmodulin on Tyr99 selectively attenuates the action of calmodulin antagonists on type-I cyclic nucleotide phosphodiesterase activity.

Authors:  M K Saville; M D Houslay
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

5.  Extracellular calcium modulates insulin's action on enzymes controlling cyclic AMP metabolism in intact hepatocytes.

Authors:  F Irvine; A V Wallace; S R Sarawak; M D Houslay
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

6.  A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors.

Authors:  R H Ganderton; K K Stanley; C E Field; M P Coghlan; M A Soos; K Siddle
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

7.  Analysis of the adenylate cyclase signalling system, and alterations induced by culture with insulin, in a novel SV40-DNA-immortalized hepatocyte cell line (P9 cells).

Authors:  C Livingstone; C MacDonald; B Willett; M D Houslay
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.